Health consumption and costs reduction in patients with ankylosing spondylitis (AS) treated with etanercept (ETA) for 2 years.

被引：0
|
作者：
Benhamou, Mathilde
Kolta, Sami
Briot, Karine
Roux, Christian
Dougados, Maxime
Fautrel, Bruno
机构：
[1] Univ Paris 05, Cochin Hosp, Dept Rheumatol, Paris, France
[2] Univ Paris 06, Pitie Salpetriere Hosp, Dept Rheumatol, Paris, France
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S718 / S719
页数：2
相关论文
共 50 条
  • [1] Elevated liver enzymes in patients with ankylosing spondylitis treated with etanercept
    van Denderen, J. C.
    Blom, G. J.
    van der Horst-Bruinsma, I. E.
    Dijkmans, B. A. C.
    Nurmohamed, M. T.
    CLINICAL RHEUMATOLOGY, 2012, 31 (12) : 1677 - 1682
  • [2] Elevated liver enzymes in patients with ankylosing spondylitis treated with etanercept
    J. C. van Denderen
    G. J. Blom
    I. E. van der Horst-Bruinsma
    B. A. C. Dijkmans
    M. T. Nurmohamed
    Clinical Rheumatology, 2012, 31 : 1677 - 1682
  • [3] WORK PRODUCTIVITY IN EMPLOYED PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH ETANERCEPT
    Boonen, A.
    Boone, C.
    Boon, T.
    Albert, A.
    Mielants, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 785 - 785
  • [4] Sustained efficacy of etanercept in ankylosing spondylitis for up to 2 years
    Davis, JC
    Van der Heijde, DM
    Braun, J
    Dougados, M
    Cush, J
    Clegg, DO
    Inman, RD
    Kivitz, A
    Zhou, L
    Tsuji, W
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 336 - 336
  • [5] WORK PRODUCTIVITY IN A COHORT OF EMPLOYED ANKYLOSING SPONDYLITIS PATIENTS TREATED WITH ETANERCEPT
    Boonen, A.
    Boone, C.
    Albert, A.
    Mielants, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 289 - 289
  • [6] Ankylosing spondylitis patients treated with infliximab had a sustained improvement in quality of life over two years.
    Braun, J.
    Kellner, H.
    Deodhar, A.
    Inman, R.
    Baker, D.
    Han, C.
    Han, J.
    Bala, M.
    van der Heijde, D.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S476 - S477
  • [7] Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years.
    Van den Bosch, F
    Devinck, M
    Kruithof, E
    Hoffman, I
    Verbruggen, G
    De Keyser, F
    Mielants, H
    Veys, E
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S635 - S635
  • [8] Long term efficacy and safety of patients with ankylosing spondylitis treated with etanercept for years - Analysis of different types of response
    Baraliakos, X.
    Listing, J.
    Fritz, C.
    Song, I. H.
    Haibel, H.
    Heldmann, F.
    Brandt, J.
    Rudwaleit, M.
    Sieper, J.
    Braun, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 745 - 746
  • [9] Comparison of healthcare costs in patients with ankylosing spondylitis who received etanercept or infliximab therapy
    Tang, B.
    Rahman, M.
    Meissner, B.
    Thompson, H.
    Karpovich, N.
    Dabbous, O.
    RHEUMATOLOGY, 2008, 47 : II118 - II118
  • [10] Comparison of healthcare costs in patients with ankylosing spondylitis who received etanercept or infliximab therapy
    Rahman, M.
    Tang, B.
    Meissner, B.
    Thompson, H.
    Dabbous, Q.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 272 - 272
12345